Cyclophosphamide post HSCT as sole immunosupression

http://jco.ascopubs.org/content/early/2014/09/29/JCO.2013.54.0625

Quite interesting paper. Summary: two doses of cyclophosphamide after HSCT lower occurence of GvHD when compared to standard immunosuppression. Somehow – not unexpected. Given how cyclophosphamide works in haploidentical HSCT and autoimmunediseaes. I just wonder can we do the same in organ transplants.

Advertisements
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s